The Impact of Obesity Medications on Chronic Disease Management: From Research to Practice
Date: April 17
Time: 1-2:30 p.m. (Central time)
The landscape of obesity care continues to evolve with the emergence of pharmaceutical interventions that target not only metabolic pathways to address obesity but also other chronic diseases. Join us for an in-depth webinar exploring the science behind FDA-approved obesity medications, including GLP-1 analogs and other incretin-based therapies, and their physiological effects with implications for chronic disease management.
This webinar is designed for registered dietitian nutritionists seeking to advance their knowledge of these groundbreaking treatments with implications for patient care. Don't miss this opportunity to enhance your role in contemporary nutrition practice and obesity care.
The Academy of Nutrition and Dietetics Foundation is pleased to offer a second three-part webinar series focused on the latest science on Obesity Medications and the impact on advancing nutrition and dietetics practice. This webinar series is made possible through a sponsorship from Eli Lilly to the Academy Foundation.
This webinar does not provide CPE credit.
Learning Objectives
- Discuss the proposed new definition and diagnostic criteria for obesity.
- Describe the basics of pharmaceutical research for FDA approval of a new medication.
- Explain how obesity management medications (GLP-1 analogs, incretin-based therapies and future categories) impact human physiology to produce weight loss.
- Explain the physiology and research to date on how the above obesity medications impact other chronic conditions.
- Outline ways that RDNs can inform themselves on the evolving science of obesity management medications and translate the science to their target populations.
Dr. Robert Kushner
Speaker
Dr. Robert Kushner has a long, distinguished career as one of the most highly respected weight management experts in the world. He is Medical Director of the Center for Lifestyle Medicine at Northwestern Medicine in Chicago, Professor of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Past President of The Obesity Society and a founder of the American Board of Obesity Medicine (ABOM) that certifies physicians in the care of patients with obesity.
Board-certified in internal medicine and nutrition, Dr. Kushner is a passionate clinician, educator, researcher and advocate in helping to improve the lives of those affected by overweight and obesity. A noted national and international speaker, Dr. Kushner teaches health care professionals about both the science and art of helping individuals lose weight, keep it off and embrace the healthier habits that fit their lives.
Jaime Almandoz, MD, MBA, MRCPI, FTOS
Speaker
Jaime Almandoz, MD, MBA, MRCPI, FTOS is an Associate Professor of Internal Medicine and Medical Director of the Weight Wellness Obesity Medicine Program at the University of Texas Southwestern Medical Center. He is board-certified in Endocrinology and Internal Medicine and a diplomate of the American Board of Obesity Medicine (ABOM).
Dr. Almandoz earned his medical degree from the Royal College of Surgeons in Ireland, completed his Internal Medicine residency and Endocrinology fellowship at the Mayo Clinic, and pursued a fellowship in Nutrition and Metabolic Diseases at UT Southwestern. He currently serves on the Board of Directors for the ABOM and as Vice Chair of the Nutrition and Obesity Disease State Network for the American Association of Clinical Endocrinology. His clinical and research interests include interdisciplinary weight management programs, post-bariatric weight recurrence, and disparities in obesity care.
Check Out Our Current Sales
From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.